Statins, but not PCSK9 inhibitors, reduce the adipokine chemerin in familial hypercholesterolemia: Focus on lipoprotein subfractions

Autor: Tan, L., Wang, N., Van Vark-Van Der Zee, L., Van Lennep, J. Roeters, Mulder, M., Lu, X., Danser, A.H., Verdonk, K.
Zdroj: In Atherosclerosis August 2023 379 Supplement 1:S173-S173
Databáze: ScienceDirect